drugset / Trial / NCT00446797

Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain

NCT00446797

Phase 4 Completed 278 enrolled Viatris Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the efficacy of celecoxib loading dose of 400mg followed by 200 mg twice a day (BID) versus oral non-selective NSAIDs in acute pain due to ankle sprain.

Timeline

Start
2007-05
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg

Indications

No indication recorded.